Transgene S.A.
TNG.PA · PAR
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | €113,961 | €89,715 | €102,976 | €138,896 |
| - Cash | €16,772 | €16,670 | €15,320 | €15,666 |
| + Debt | €30,567 | €10,396 | €90 | €1,257 |
| Enterprise Value | €127,756 | €83,441 | €87,746 | €124,487 |
| Revenue | €96 | €2,996 | €23 | €3,137 |
| % Growth | -96.8% | 12,926.1% | -99.3% | – |
| Gross Profit | €0 | -€15,859 | -€12,066 | -€10,882 |
| % Margin | 0% | -529.3% | -52,460.9% | -346.9% |
| EBITDA | -€22,040 | -€18,441 | -€18,542 | -€13,464 |
| % Margin | -22,958.3% | -615.5% | -80,617.4% | -429.2% |
| Net Income | -€19,295 | -€17,486 | -€16,485 | -€6,426 |
| % Margin | -20,099% | -583.6% | -71,673.9% | -204.8% |
| EPS Diluted | -0.15 | -0.13 | -0.16 | -0.063 |
| % Growth | -15.4% | 18.8% | -152.4% | – |
| Operating Cash Flow | -€18,185 | -€5,708 | -€18,133 | -€17,010 |
| Capital Expenditures | -€279 | -€1,062 | -€2,004 | -€1,265 |
| Free Cash Flow | -€18,464 | -€6,770 | -€20,137 | -€18,275 |